Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Cannabinoids in health and disease.

Kogan NM, Mechoulam R.

Dialogues Clin Neurosci. 2007;9(4):413-30. Review.

2.

Therapeutic potential of cannabinoids in CNS disease.

Croxford JL.

CNS Drugs. 2003;17(3):179-202. Review.

PMID:
12617697
3.

Cannabis and cannabinoids: pharmacology and rationale for clinical use.

Pertwee RG.

Forsch Komplementarmed. 1999 Oct;6 Suppl 3:12-5. Review.

PMID:
10575283
4.

Plant, synthetic, and endogenous cannabinoids in medicine.

Di Marzo V, Petrocellis LD.

Annu Rev Med. 2006;57:553-74. Review.

PMID:
16409166
5.

Cannabinoids in clinical practice.

Williamson EM, Evans FJ.

Drugs. 2000 Dec;60(6):1303-14. Review.

PMID:
11152013
6.

Behavioral effects of cannabinoid agents in animals.

Chaperon F, ThiƩbot MH.

Crit Rev Neurobiol. 1999;13(3):243-81. Review.

PMID:
10803637
7.

Cannabinoids.

Grotenhermen F.

Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):507-30. Review.

PMID:
16266285
8.

Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review.

Velayudhan L, Van Diepen E, Marudkar M, Hands O, Suribhatla S, Prettyman R, Murray J, Baillon S, Bhattacharyya S.

Curr Pharm Des. 2014;20(13):2218-30. Review.

PMID:
23829360
9.

The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies.

Rivers JR, Ashton JC.

Cent Nerv Syst Agents Med Chem. 2010 Mar;10(1):47-64. Review.

PMID:
20236042
10.

[The mechanism of action of cannabis and cannabinoids].

Scholten WK.

Ned Tijdschr Geneeskd. 2006 Jan 21;150(3):128-31. Review. Dutch.

PMID:
16463612
11.

The role of cannabinoids in neurodegenerative diseases.

Glass M.

Prog Neuropsychopharmacol Biol Psychiatry. 2001 May;25(4):743-65. Review.

PMID:
11383976
12.

Cannabinoid pharmacology: the first 66 years.

Pertwee RG.

Br J Pharmacol. 2006 Jan;147 Suppl 1:S163-71.

13.

Modulating the endocannabinoid system in human health and disease--successes and failures.

Pacher P, Kunos G.

FEBS J. 2013 May;280(9):1918-43. doi: 10.1111/febs.12260. Epub 2013 Apr 22. Review.

14.

Cannabinoid control of neuroinflammation related to multiple sclerosis.

Baker D, Jackson SJ, Pryce G.

Br J Pharmacol. 2007 Nov;152(5):649-54. Epub 2007 Sep 24. Review.

15.

Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.

Smith PF.

Curr Opin Investig Drugs. 2002 Jun;3(6):859-64. Review.

PMID:
12137404
16.

[The cannabinoid system and pain: towards new drugs?].

Beltramo M.

J Soc Biol. 2009;203(1):99-106. doi: 10.1051/jbio:2009002. Epub 2009 Apr 10. Review. French.

PMID:
19358815
17.

The role of cannabinoids in regulation of nausea and vomiting, and visceral pain.

Malik Z, Baik D, Schey R.

Curr Gastroenterol Rep. 2015 Feb;17(2):429. doi: 10.1007/s11894-015-0429-1. Review.

PMID:
25715910
18.

Pro-drugs for indirect cannabinoids as therapeutic agents.

Ashton J.

Curr Drug Deliv. 2008 Oct;5(4):243-7.

PMID:
18855592
19.

Human studies of cannabinoids and medicinal cannabis.

Robson P.

Handb Exp Pharmacol. 2005;(168):719-56. Review.

PMID:
16596794
20.

Cannabinoids and pain.

Lever IJ, Rice AS.

Handb Exp Pharmacol. 2007;(177):265-306. Review.

PMID:
17087127
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk